Profound Medical Corp. (PROF)

NASDAQ: PROF · IEX Real-Time Price · USD
9.72
0.23 (2.42%)
At close: Jan 21, 2022 4:00 PM
9.88
0.16 (1.65%)
After-hours:Jan 21, 2022 4:39 PM EST
Market Cap204.15M
Revenue (ttm)5.68M
Net Income (ttm)-18.16M
Shares Out21.00M
EPS (ttm)-1.39
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume68,055
Open9.50
Previous Close9.49
Day's Range9.26 - 9.80
52-Week Range9.26 - 28.97
Beta1.55
AnalystsStrong Buy
Price Target26.52 (+172.8%)
Earnings Daten/a

About PROF

Profound Medical Corp., together with its subsidiaries, operates as a medical technology company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with me...

IndustryHealth Care Equipment & Supplies
Employees109
Stock ExchangeNASDAQ
Ticker SymbolPROF
Full Company Profile

Financial Performance

Financial numbers in millions CADFinancial Statements

Analyst Forecast

According to 8 analysts, the average rating for PROF stock is "Strong Buy." The 12-month stock price forecast is 26.52, which is an increase of 172.84% from the latest price.

Price Target
$26.52
(172.84% upside)
Analyst Consensus: Strong Buy

News

Profound Medical Announces First Patients Treated in Prospective, Randomized Clinical Trial Comparing the TULSA Proce...

TORONTO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...

5 days ago - GlobeNewsWire

Kenneth Knudson Joins Profound Medical as Chief Commercial Officer

TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...

2 weeks ago - GlobeNewsWire

Profound Medical (PROF) Reports Q3 Loss, Lags Revenue Estimates

Profound Medical (PROF) delivered earnings and revenue surprises of -11.54% and -36.58%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Profound Medical Announces Third Quarter 2021 Financial Results

TORONTO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...

2 months ago - GlobeNewsWire

Profound Medical to Participate in November Virtual Investor Conferences

TORONTO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...

2 months ago - GlobeNewsWire

Will Profound Medical (PROF) Report Negative Earnings Next Week? What You Should Know

Profound Medical (PROF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Profound Medical to Release Third Quarter 2021 Financial Results on November 4 – Conference Call to Follow

TORONTO, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...

3 months ago - GlobeNewsWire

Profound Medical to Participate in September Virtual Investor Conferences

TORONTO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable,...

4 months ago - GlobeNewsWire

PROFOUND MEDICL (PROF) Reports Q2 Loss, Tops Revenue Estimates

PROFOUND MEDICL (PROF) delivered earnings and revenue surprises of -34.62% and 15.98%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Profound Medical Announces Second Quarter 2021 Financial Results

TORONTO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...

5 months ago - GlobeNewsWire

PROFOUND MEDICL (PROF) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

PROFOUND MEDICL (PROF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

Profound Medical to Participate in A.G.P.'s Virtual MedTech Summer Conference

TORONTO, July 22, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...

6 months ago - GlobeNewsWire

Profound Medical to Release Second Quarter 2021 Financial Results on August 4 – Conference Call to Follow

TORONTO, July 15, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...

6 months ago - GlobeNewsWire

Profound Medical to Participate in June Investor Conferences

TORONTO, May 25, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable,...

7 months ago - GlobeNewsWire

Profound Medical Announces Voting Results from the 2021 Annual Meeting of Shareholders and Management Changes

TORONTO, May 19, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual Meeting of Shareholders ...

8 months ago - GlobeNewsWire

Profound Medical Announces First Quarter 2021 Financial Results

TORONTO, May 12, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, i...

8 months ago - GlobeNewsWire

Analysts Estimate PROFOUND MEDICL (PROF) to Report a Decline in Earnings: What to Look Out for

PROFOUND MEDICL (PROF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

Profound Medical to Release First Quarter 2021 Financial Results on May 12 – Conference Call to Follow

TORONTO, April 21, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable,...

9 months ago - GlobeNewsWire

Profound Medical to Participate in the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference

TORONTO, April 14, 2021 (GLOBE NEWSWIRE) --  Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable...

9 months ago - GlobeNewsWire

Profound Medical Announces the Appointment of Cynthia Lavoie to its Board of Directors

TORONTO, March 03, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free th...

10 months ago - GlobeNewsWire

PROFOUND MEDICL (PROF) Reports Q4 Loss, Lags Revenue Estimates

PROFOUND MEDICL (PROF) delivered earnings and revenue surprises of -40.74% and -4.95%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

10 months ago - Zacks Investment Research

Profound Medical Announces Fourth Quarter and Full Year 2020 Financial Results

TORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable,...

10 months ago - GlobeNewsWire

Profound Medical to Participate in March Virtual Investor Conferences

TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free the...

10 months ago - GlobeNewsWire

Profound Medical to Participate in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Confer...

TORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free the...

11 months ago - GlobeNewsWire

Profound Medical to Release Fourth Quarter and Full Year 2020 Financial Results on March 2 – Conference Call to Follow

TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free the...

11 months ago - GlobeNewsWire